NCT01870024View on ClinicalTrials.gov

Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus

PHASE3CompletedINTERVENTIONAL
Enrollment

434

Participants

Timeline

Start Date

June 26, 2013

Primary Completion Date

February 23, 2018

Study Completion Date

February 23, 2018

Conditions
Status EpilepticusEpilepsy
Interventions
DRUG

Clonazepam

clonazepam 0,015 mg/kg

DRUG

Fosphenytoin

fosphenytoin 20 mg/kg Equivalent Phenytoin (EP) by intravenous infusion over a period of 15 minutes

DRUG

Placebo

placebo 20 mg/kg by intravenous infusion over a period of 15 minutes

DRUG

Lorazepam

lorazepam 0,1mg/kg by intravenous injection over a period of 2 to 3 minutes)

Trial Locations (1)

75010

Département d'Anesthésie - Réanimation - SMUR - Hôpital Lariboisière, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01870024 - Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus | Biotech Hunter | Biotech Hunter